Macrogen Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Macrogen Inc cash flow conversion efficiency. Based on the latest financial reports, Macrogen Inc (038290) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.10 Billion ≈ $4.81 Million USD) by net assets (₩168.36 Billion ≈ $114.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Macrogen Inc (2011–2024)

Cash flow conversion efficiency of Macrogen Inc from 2011 to 2024. This chart illustrates how Macrogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Macrogen Inc stock quote for real-time trading data and today's change.

Macrogen Inc Cash Flow Conversion Ratio Explained

Macrogen Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Macrogen Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Macrogen Inc ranked by their cash flow conversion efficiency. Also see Macrogen Inc market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Charoong Thai Wire and Cable Public Company Limited BK:CTW	-0.004x
Ganesh Benzoplast Limited NSE:GANESHBE	0.065x
Qualicorp Consultoria e Corretora de Seguros S.A SA:QUAL3	-0.027x
Korfez Gayrimenkul Yatirim IS:KRGYO	-0.004x
Swift Haulage Bhd KLSE:5303	0.041x
Aiptek International Inc TW:6225	0.013x
Agile Group Holdings Limited F:A8P	0.153x
Tonix Pharmaceuticals Holding Corp NASDAQ:TNXP	-0.162x

Annual Cash Flow Conversion Efficiency for Macrogen Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of Macrogen Inc from 2011 to 2024. Review Macrogen Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩177.43 Billion ≈ $120.24 Million	₩7.12 Billion ≈ $4.83 Million	0.040x	+34.13%
2023-12-31	₩159.19 Billion ≈ $107.88 Million	₩4.77 Billion ≈ $3.23 Million	0.030x	-50.14%
2022-12-31	₩179.32 Billion ≈ $121.52 Million	₩10.77 Billion ≈ $7.30 Million	0.060x	-43.13%
2021-12-31	₩200.64 Billion ≈ $135.97 Million	₩21.18 Billion ≈ $14.36 Million	0.106x	+1.79%
2020-12-31	₩198.15 Billion ≈ $134.28 Million	₩20.55 Billion ≈ $13.93 Million	0.104x	-18.91%
2019-12-31	₩113.33 Billion ≈ $76.80 Million	₩14.50 Billion ≈ $9.82 Million	0.128x	-3.28%
2018-12-31	₩118.01 Billion ≈ $79.98 Million	₩15.61 Billion ≈ $10.58 Million	0.132x	-4.58%
2017-12-31	₩94.28 Billion ≈ $63.89 Million	₩13.07 Billion ≈ $8.86 Million	0.139x	-46.15%
2016-12-31	₩82.55 Billion ≈ $55.94 Million	₩21.25 Billion ≈ $14.40 Million	0.257x	+173.79%
2015-12-31	₩76.11 Billion ≈ $51.58 Million	₩7.15 Billion ≈ $4.85 Million	0.094x	-4.15%
2014-12-31	₩67.13 Billion ≈ $45.49 Million	₩6.58 Billion ≈ $4.46 Million	0.098x	-35.74%
2013-12-31	₩60.05 Billion ≈ $40.69 Million	₩9.16 Billion ≈ $6.21 Million	0.153x	-28.37%
2012-12-31	₩51.71 Billion ≈ $35.05 Million	₩11.02 Billion ≈ $7.47 Million	0.213x	-17.57%
2011-12-31	₩43.11 Billion ≈ $29.21 Million	₩11.14 Billion ≈ $7.55 Million	0.258x	--

About Macrogen Inc

KQ:038290 Korea Biotechnology & Medical Research

Market Cap

$73.75 Million

₩108.83 Billion KRW

Market Cap Rank

#20196 Global

#1073 in Korea

Share Price

₩10860.00

Change (1 day)

-1.27%

52-Week Range

₩10700.00 - ₩19520.00

All Time High

₩49726.89